Qure.ai is an Artificial Intelligence (AI) solutions provider for medical imaging diagnostics assisting clinicians in accurately and quickly interpreting time-bound critical scans. Qure’s solutions are targeted to support radiology workflows with triage and faster treatment decision-making, enabling better patient outcomes. Qure’s flagship products include:
· qER (Head CT interpretation & triage).
· qXR (CXR interpretation).
· qCT (chest CT interpretation).
· qMSK (MSK X-ray interpretation).
Qure.ai is one of the most reputed companies in AI medical imaging, with deployments in over 70+ countries, including the UK’s NHS, impacting 12+ million patient lives globally.
The UK’s healthcare system is overwhelmed, with increasingly crowded departments and overburdened staff. As a result, patients queuing for admissions have become a common sight in A&E departments in many NHS Trusts.
qER is an AI algorithm developed to accurately interpret multiple abnormalities on a non-contrast head CT scan and deliver reports to clinicians in under < 3 minutes. When treating patients in A&E, speed and accuracy are pivotal. qER is specifically designed to address some of the problems faced by Emergency Medicine consultants by reducing the time to diagnosis and speeding up the treatment decision-making process.
qER empowers Emergency Medicine consultants to make faster treatment decisions for suspected stroke cases, whether to admit/ transfer/ discharge the patients, and helps them to manage patient inflows & outflows better. It also acts as a second set of eyes to avoid missing any subtle abnormalities on a head CT, especially in the after-hours workflows.
qER is an FDA-cleared and CE class IIb-approved product and the first-ever medical AI algorithm to be featured in the Lancet. qER has also won an NHSxAI award and is currently deployed in multiple NHS trusts across the UK.
Galen is privately owned pharmaceutical company established in 1968, with global headquarters in Craigavon, Northern Ireland and and product presence in 25 locations covering each continent across the globe.
With over 50 years’ experience, Galen have 75+ products across a diverse range of therapy areas including emergency care, oncology, gastroenterology and dermatology.
Galen is the proud founding member of the Almac Group of world-class companies in the pharmaceutical and biotech sectors. The Group is wholly owned by the McClay Foundation, a charitable institution, whose overarching aim is to make a meaningful improvement and advancement in human health.
Galen is the exclusive distributor of Penthrox (methoxyflurane) in the UK and Ireland.
Aidoc is the leading provider of AI for Enterprise Imaging with a focus on the detection and triage of acute, life-threatening and time-sensitive pathologies on CT and X-ray images.
Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimise patient treatment, which results in improved clinical outcomes and economic value.
Aidoc’s clinically proven AI solutions eliminate silos, increase efficiencies, and improve outcomes by delivering critical information when and where care teams need it leading to immediate collective action.
Built on Aidoc’s exclusive aiOS, we analyse and aggregate medical data to enable care teams to operationalise the unexpected and work seamlessly with a continued focus on the patient. Aidoc AI is always on, running in the background to change the foreground.
As one of the world’s leading medical technology companies, B. Braun aims to protect and improve the health of people around the world.
Our latest innovations in IV administration sets are helping to improve patient outcomes by enabling the total dose delivery of prescribed antibiotics and preventing significant underdosing that is commonplace with current administration sets and the introduction of our longer length peripheral IV catheters are helping to facilitate successful catheter insertions in patients with difficult intravenous access, reducing failed cannulation attempts and improving catheter survival rates.
To find out more about these latest innovations, you can visit the B. Braun exhibition stand or get in touch with us at IVTherapy.email@example.com
I'm a paragraph. Click here to add your own text and edit me. It's easy.
When time counts, rely on Teleflex to support clinicians with innovative solutions for your intraosseous vascular access, rescue airway, atomization and intubation needs. Teleflex are based in Beaconsfield, Berkshire.
Abbott is a global healthcare leader that helps people live their best lives through better health. Available in 160 countries around the world, our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. The i-STAT System is an advanced, portable diagnostic tool that provides real-time, lab-quality results within minutes to accelerate patient-care decision-making. The i-STAT System provides a comprehensive menu of tests in a single, point-of-care platform, including tests for blood gases, electrolytes, chemistries, coagulation, hematology, glucose, and cardiac markers. Continuing its efforts to bring the world more efficient diagnostic solutions, Abbott recently received FDA clearance for its innovative i-STAT TBI Plasma test, the first rapid traumatic brain injury (TBI) blood plasma test that can help clinicians assess suspected mild TBIs, including concussions.
AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence.
ZOLL develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnoea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com/uk